证券记录 · 已归档季度
AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
13被追踪持有人
+3Δ持有人
21.14M持有股份
$177.14M报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 +2.4% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | -4 | 106.56M | $1.84B | +7 | −10 |
| Q1 2026 | 107 | -1 | 100.53M | $1.25B | +9 | −11 |
| Q4 2025 | 109 | 0 | 106.30M | $1.34B | +1 | — |
| Q3 2025 | 18 | 0 | 61.16M | $612.26M | — | — |
| Q2 2025 | 15 | -1 | 52.63M | $425.79M | — | −1 |
| Q1 2025 | 13 | +3 | 21.14M | $177.14M | +3 | — |
| Q4 2024 | 10 | -1 | 20.64M | $163.48M | — | −1 |
| Q3 2024 | 10 | 0 | 16.87M | $140.36M | +2 | −2 |
| Q2 2024 | 10 | — | 16.56M | $105.19M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 7.49M | -16.6% | $62.78M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 7.49M | -16.6% | $62.78M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 3.83M | +0.3% | $32.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 3.83M | +0.3% | $32.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 3.69M | -0.2% | $30.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 2.09M | +57.6% | $17.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.79M | +16.4% | $15.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 745.48K | +121.3% | $6.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 745.48K | +121.3% | $6.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 745.48K | +121.3% | $6.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 745.48K | +121.3% | $6.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 745.48K | +121.3% | $6.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 624.70K | -9.0% | $5.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 446.00K | 新增 | $3.74M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 167.70K | 新增 | $1.41M | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 126.68K | +30.3% | $1.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 70.05K | -5.4% | $587,036 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 70.05K | -5.4% | $587,036 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 70.05K | -5.4% | $587,036 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 70.05K | -5.4% | $587,036 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 52.67K | -40.1% | $441,366 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 15.84K | 新增 | $132,706 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $3.74M | 0.0% |
| Two Sigma Investments | $1.41M | 0.0% |
| D. E. Shaw & Co. | $132,706 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 314 持有人, 158.91M 股份, $1.92B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Kiely John
Director · 50.00K 股 · $882,000
Aug 12
Shah Nikita
Officer · 146.40K 股 · $2.56M
Aug 12
Daly Jason B.
Officer · 210.00K 股 · $3.65M
Aug 11
Daly Jason B.
Officer · 6.61K 股 · $117,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 12
SC 13D/A — Patel Tushar Bhikhubhai
17.6% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chirag K.
8.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chintu
9.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据